Social and behavioural influences on the uptake of hormone replacement therapy among younger women

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 6, 2000, Pages 731-739

  Kuh, Diana ^a   Hardy, Rebecca ^a   Wadsworth, Michael ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRADIOL VALERATE PLUS NORETHISTERONE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTROGEN; KLIOFEN; MEDROXYPROGESTERONE ACETATE PLUS ESTRADIOL; ORAL CONTRACEPTIVE AGENT; PREMIQUE; PREMPAK; TIBOLONE; TRIDESTRA; TRISEQUENS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG USE; EARLY MENOPAUSE; FEMALE; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OSTEOPOROSIS; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SMOKING HABIT; SOCIAL CLASS; UNITED KINGDOM;

ADULT; AGE FACTORS; ATTITUDE TO HEALTH; COHORT STUDIES; EDUCATIONAL STATUS; ENGLAND; FEMALE; HEALTH BEHAVIOR; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; SCOTLAND; SOCIAL BEHAVIOR; SOCIAL CLASS; SOCIAL CONFORMITY; WALES;

EID: 0034023372     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13333.x     Document Type: Article

References (49)

1. Moorhead T, Hannaford P, Warskyi M. Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 1997; 104: 290–297.
2. Townsend J. Hormone replacement therapy: assessment of present use, costs and trends. Br J Gen Pract 1998; 48: 955–958.
3. Criqui MH, Surrez KA, Barrett-Connor E, McPhilips J, Wingard DL, Garland C. Postmenopausal estrogen use and mortality. Am J Epidemiol 1988; 128: 606–614.
4. Matthews KA, Kuller LH, Wing RR. Prior to use of estrogen replacement therapy, are users healthier than nonusers Am J Epidemiol 1996; 143: 971–978.
5. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994; 140: 439–451.
6. Derby CA, Hume AL, McFarland Barbour M, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two Southeastern New England communities. Am J Epidemiol 1993; 137: 1125–1135.
7. Persson J, Adami H-O, Bergstrom R, Krusemo U-B, Hoove R. Survival in women receiving hormone replacement therapy. J Clin Epidemiol 1990; 43: 677–685.
8. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993; 46: 211–219.
9. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease and other considerations. Annu Rev Publ Health 1998; 19: 55–72.
10. Barrett-Connor E. Hormone replacement therapy. BMJ 1998; 317: 457–461.
11. Wadsworth MEJ, Mann SL, Rodgers B, Kuh DL, Hilder WS, Yusuf EF. Loss and representativeness in a 43 year follow-up of a national birth cohort. J Epidemiol Community Health 1992; 46: 300–304.
12. Wadsworth MEJ, Kuh DJL. Childhood influences on adult health: a review of recent work in the British 1946 national birth cohort study, the MRC National Survey of Health and Development. Paediat Perinat Epidemiol 1997; 11: 2–20.
13. Kuh DL, Wadsworth M, Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 1997; 104: 923–933.
14. Kuh D, Stirling S. Socioeconomic variation in admission for diseases of female genital system and breast in a national cohort aged 15–43. BMJ 1995; 311: 840–843.
15. Wadsworth MEJ, Cripps HA, Midwinter RA, Colley JRT. Blood pressure at age 36 years and social and familial factors, cigarette smoking and body mass in a national birth cohort. BMJ 1985; 291: 1534–1538.
16. Braddon FEM, Rodgers B, Wadsworth MEJ, Davies JMC. Onset of obesity in a 36 year birth cohort study. BMJ 1986; 293: 299–303.
17. Wing JK, Cooper JE, Sartorius N. Present State Examination. London: Cambridge University Press, 1974.
18. Wing JK, Nixon JM, Mann SA, Leff JP. Reliability of the PSE (ninth edition) used in a population study. Psychol Med 1977; 7: 505–516.
19. Rodgers B. Adult affective disorder and early environment. Br J Psych 1990; 157: 539–550.
20. Braddon FEM, Wadsworth MEJ, Davies JMC, Cripps HA. Social and regional differences in food and alcohol consumption and their measurement in a national birth cohort. J Epidemiol Com Health 1988; 42: 341–349.
21. Kuh DJL, Wadsworth MEJ. Physical health status at 36 years in a British national birth cohort. Soc Sci Med 1993; 37: 905–916.
22. Britten N. Validity of claims to lifelong non-smoking at age 36 in a longitudinal study. Int J Epidemiol 1988; 17: 525–529.
23. Kuh DJL, Cooper C. Physical activity at 36 years: patterns and childhood predictors in a longitudinal study. J Epidemiol Com Health 1992; 46: 114–119.
24. Cox DR. Regression models and life-tables (with discussion). J Roy Stat Soc 1972; 34: 187–220.
25. Kalbfleisch ID, Prentice FU. The Statistical Analysis of Failure Erne Data. New York: John Wiley, 1980.
26. Cox DR, Oakes D. Analysis ofSurvival Dam. London: Chapman & Hall, 1984.
27. SAS Technical Report 229: SAS/STATS Software: Changes and Enhancements. SAS Institute Inc; Cary, North Carolina, USA 1992.
28. Brambilla D, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994; 140: 1091–1095.
29. Lancaster T, Surman G, Lawrence M et al. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Com Health 1995; 49: 389–394.
30. Grodstein F, Stampfer MJ, Manson JE et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–461.
31. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of noncontraceptive hormone users. Prev Med 1988; 17: 403–411.
32. Marks NF, Shinberg DS. Socioeconomic status differences in hormone therapy. Am J Epidemiol 1998; 148: 1–13.
33. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen use in a population study. Am J Obstet Gynecol 1990; 163: 1438–1444.
34. Persson I, Adami H-O, Lindberg BS, Johansson EDB, Manel P. Characteristics of estrogen-treated women. Acta Obstet Gynecol Scand 1983; 62: 297–302.
35. Barrett-Connor E, Wingard DL, Criqui MH. Post-menopausal estrogen use and heat disease risk factors in the 1980s. JAMA 1989; 261: 2095–2100.
36. Greenberg G, Thompson SG, Meade TW. Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol Com Health 1987; 41: 26–29.
37. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985; 103: 350–356.
38. Hardy R, Kuh D. Reproductive characteristics and the age at inception of perimenopause in a British national cohort. Am J Epidemiol 1999; 149: 1–9.
39. Kuh D, Richards M, Hardy R, Wadsworth MEJ. Lifetime predictors of early menopause: findings from a British birth cohort study. J Br Menopause Soc 1999; 4 (Suppl 1): 19.
40. Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses Health Study. N Engl J Med 1991; 325: 756–762.
41. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997; 145: 536–545.
42. Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 1987; 94: 620–635.
43. Rosenburg L, Shapiro D, Kaufman DW, Slone D, Miettinen OS, Stolley PD. Patterns and determinants of conjugated estrogen use. Am J Epidemiol 1979; 109: 676–686.
44. Stadel BV, Weiss N. Characteristics of menopausal women—a survey of King and Pierce counties in Washington, 1973–1974. Am J Epidemiol 1975; 102: 209–216.
45. Standeven M, Criqui MH, Klauber MR, Gabriel S, Barrett-Connor E. Correlates of change in postmenopausal estrogen use in a population-based study. Am J Epidemiol 1986; 124: 268–274.
46. Richards M, Kuh DL, Hardy R, Wadsworth MEJ. Lifetime cognitive function and timing of the natural menopause. Neurology 1999; 53: 308–314.
47. Bastian LA, Couchman GM, Rimer BK, McBride CM, Feaganes JR, Siegler IC. Perceptions of menopausal stage and patterns of hormone replacement therapy use. J Women's Health 1997; 6: 467–475.
48. Whitlock EP, Johnson RE, Vogt TM. Recent patterns of hormone replacement therapy use in a large managed care organization. J Women's Health 1998; 8: 1017–1026.
49. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985; 313: 1044–1049.